Wen‐Pin Su

Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer

Jin‐Yuan Shih, Chien‐Hung Gow, Chong‐Jen Yu et al. · International Journal of Cancer · 2005 · 172 citations

Medicine, Oncology, Pathology +17

PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells

Wu‐Chou Su, Wen‐Pin Su, Cheng Cheng et al. · International Journal of Nanomedicine · 2012 · 150 citations · Full text

Pharmacy, Oncology, Pharmacology +16

Metformin Enhances Cisplatin Cytotoxicity by Suppressing Signal Transducer and Activator of Transcription–3 Activity Independently of the Liver Kinase B1–AMP-Activated Protein Kinase Pathway

Chien‐Chung Lin, Hsuan-Heng Yeh, Wei-Lun Huang et al. · American Journal of Respiratory Cell and Molecular Biology · 2013 · 103 citations

Medicine, Oncology, Pharmacology +9

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial

Daniel P. Petrylak, Ronald de Wit, Kim N. et al. · The Lancet Oncology · 2019 · 85 citations · Full text

Medicine, Oncology, Pharmacology +16

Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer

Wen‐Pin Su, Yen‐Ting Chen, Wu‐Wei Lai et al. · Lung Cancer · 2010 · 83 citations

Medicine, Molecular Biology, Oncology +15